Literature DB >> 6812491

Analysis of the in vitro interaction between vancomycin and cholestyramine.

C Y King, S L Barriere.   

Abstract

Vancomycin and cholestyramine have been utilized both alone and in combination for the treatment of antibiotic-associated pseudomembranous colitis. Previous work for the treatment of antibiotic-associated pseudomembranous colitis. Previous work has demonstrated significant binding of vancomycin by the anion-exchange resin. The antibacterial activity of vancomycin was markedly reduced when the suspension was centrifuged and the supernatant was tested for antibacterial activity. This study confirmed these findings but demonstrated that there was no immediate loss of antibacterial activity of bound vancomycin. The degree of inactivation appeared to be dependent upon the duration of incubation of vancomycin and cholestyramine in the testing system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6812491      PMCID: PMC181420          DOI: 10.1128/AAC.19.2.326

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Some laboratory and clinical experiences with a new antibiotic, vancomycin.

Authors:  J E GERACI; F R HEILMAN; D R NICHOLS; G T ROSS; W E WELLMAN
Journal:  Proc Staff Meet Mayo Clin       Date:  1956-10-17

2.  Relapse of pseudomembranous colitis after vancomycin therapy.

Authors:  W L George; N A Volpicelli; D B Stiner; D D Richman; E J Liechty; H Y Mok; R D Rolfe; S M Finegold
Journal:  N Engl J Med       Date:  1979-08-23       Impact factor: 91.245

3.  Stability of parenteral solutions of sodium cephalothin, cephaloridine, potassium penicillin G (buffered) and vancomycin hydrochloride.

Authors:  J M Mann; D L Coleman; J C Boylan
Journal:  Am J Hosp Pharm       Date:  1971-10

4.  Anion-exchange resins in pseudomembranous colitis.

Authors:  R H George; D J Youngs; E M Johnson; D W Burdon
Journal:  Lancet       Date:  1978-09-16       Impact factor: 79.321

5.  Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; F J Tedesco; S Shull; B Lowe; T Chang
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

6.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

7.  Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.

Authors:  M R Keighley; D W Burdon; Y Arabi; J A Williams; H Thompson; D Youngs; M Johnson; S Bentley; R H George; G A Mogg
Journal:  Br Med J       Date:  1978-12-16

8.  Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins.

Authors:  N S Taylor; J G Bartlett
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

Review 9.  Antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett
Journal:  Rev Infect Dis       Date:  1979 May-Jun

10.  Therapy of antibiotic-associated pseudomembranous colitis.

Authors:  F J Tedesco; J Napier; W Gamble; T W Chang; J G Bartlett
Journal:  J Clin Gastroenterol       Date:  1979-03       Impact factor: 3.062

View more
  2 in total

1.  Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestyramine.

Authors:  A Pantosti; I Luzzi; R Cardines; P Gianfrilli
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

2.  Binding interactions with sevelamer and polystyrene sulfonate in vitro.

Authors:  Inge R F van Berlo-van de Laar; Ilona Prins-Can; Aliesa A de Lange; Katja Taxis; Frank G A Jansman
Journal:  Pharmacol Res Perspect       Date:  2021-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.